Haemonetics
Update in progressHAE (NYSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
Haemonetics is a medical technology company that provides hospital solutions globally. It offers automated plasma collection systems and donor management software, including NexSys PCS, PCS2, NexLynk DMS, and Donor360, plus IT platforms to manage donors, operations and supply chains. It markets devices such as SavvyWire and OptoWire, fiber optic sensor solutions, and TEG hemostasis analyzers with TEG Manager. Also offered are Cell Saver Elite+ and VASCADE closure devices. Founded 1971, Boston.
Company score
- Sentiment
- 0.09
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- -0.16
- Governance
- 0.05
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.04
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.02
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!